Chong Kun Dang Pharmaceutical Corp.

KSE 185750.KS

Chong Kun Dang Pharmaceutical Corp. Dividend Yield on January 14, 2025: 1.07%

Chong Kun Dang Pharmaceutical Corp. Dividend Yield is 1.07% on January 14, 2025, a 29.87% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Chong Kun Dang Pharmaceutical Corp. 52-week high Dividend Yield is 1.18% on December 09, 2024, which is 9.78% above the current Dividend Yield.
Chong Kun Dang Pharmaceutical Corp. 52-week low Dividend Yield is 0.75% on September 03, 2024, which is -30.17% below the current Dividend Yield.
Chong Kun Dang Pharmaceutical Corp. average Dividend Yield for the last 52 weeks is 0.92%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

KSE: 185750.KS

Chong Kun Dang Pharmaceutical Corp.

CEO	Mr. Young-Joo Kim
IPO Date	Dec. 6, 2013
Location	South Korea
Headquarters	8, Chungjeong-ro
Employees	2,286
Sector	Health Care
Industries Pharmaceuticals Consumer Packaged Goods Drugstores & Retail Pharmacies

Description

Chong Kun Dang pharmaceutical Corp. engages in the manufacturing, marketing, and selling of medicines in South Korea and internationally. It provides prescription drugs for anti-hypertension, anti-hyperlipidemia, and anti-diabetics; over-the-counter drugs, such as Penzal, Prefemine, and Modcol, as well as consumer health products, such as insecticides, hair dye, etc.; and healthcare supplements with preventive benefits. The company also exports its products. Chong Kun Dang pharmaceutical Corp. was founded in 1941 and is headquartered in Seoul, South Korea.

Key trends

Past 5 years